What is “Test to Treat”?

▪ Test to Treat (sometimes abbreviated as “T2T”) is a strategy to streamline early COVID-19 diagnosis and prompt treatment with oral antiviral drugs for patients at increased risk of severe COVID-19.

▪ Step one (“Test”) is to identify symptomatic patients within five days of symptom onset and perform a test— ideally a rapid diagnostic test—to confirm COVID-19 infection.

▪ Step two (“to Treat”) is to identify patients who are at high risk for developing severe illness or death from COVID-19 and initiate oral antiviral treatment in such patients.

▪ In the Test to Treat strategy, all positive COVID-19 patients can have streamlined access to evidence-based care, even if they are not eligible for oral antivirals, and all patients should be educated and monitored throughout the course of their illness for symptom resolution.

-By EPiC FHI360